Page last updated: 2024-10-27

fluorouracil and Capsule Opacification

fluorouracil has been researched along with Capsule Opacification in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Capsule Opacification: Clouding or loss of transparency of the posterior lens capsule, usually following CATARACT extraction.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, X1
Wang, Y1
Cai, JP1
Ma, XY1
Li, Y1
Cheng, JW1
Wei, RL1

Other Studies

1 other study available for fluorouracil and Capsule Opacification

ArticleYear
Sustained release of 5-fluorouracil from chitosan nanoparticles surface modified intra ocular lens to prevent posterior capsule opacification: an in vitro and in vivo study.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2013, Volume: 29, Issue:2

    Topics: Animals; Capsule Opacification; Cells, Cultured; Chitosan; Delayed-Action Preparations; Epithelial C

2013